Patent ID: 6455267
Filing Date: 2002-09-24
Classification: A61K,A61P,C07K,C12N,C12Y,G01N,Y10S

Abstract:
A method for determining the status of a GAD associated autoimmune disorder in a patient which comprises contacting T-cells of said patient with at least one peptide that is selected from the group consisting of:(a) KPCSCSKVDVNYAFLHATDL (SEQ ID NO:06); (b) NMYAMMIARFKMFPEVKEKG (SEQ ID NO:07); (c) TAGTTVYGAFDPLLAVADICKK (SEQ ID NO:08); (d) EYLYNIIKNREGYEMVFDGK (SEQ ID NO:09); (e) IPPSLRYLEDNEERMSRLSK (SEQ ID NO:10); (f) SRLSKVAPVIKARMMEYGTT (SEQ ID NO:11); (g) EYGTTMVSYQPLGDKVNFFR (SEQ ID NO:12); and (h) ATHQDIDFLIEEIERLGQDL (SEQ ID NO:13).